TFAIP6通过上调c-myc/PKM2轴来促进肝细胞癌细胞糖解
Kecai Duan1, Kunpeng Fang1, Chengjun Sui1
1Department of Special Medical Services, Third Affiliated Hospital of Naval Medical University (Shanghai Eastern Hepatobiliary Surgery Hospital), China.
Heliyon
|May 30, 2024
概括
瘤坏死因子-α刺激基因-6 (TNFAIP6) 通过增强有氧糖解促进肝细胞癌 (HCC) 的生长. 针对TNFAIP6可能为HCC患者提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 肝细胞癌 (HCC) 是最常见的肝癌,治疗选择有限.
- 了解HCC分子机制对于改善患者的治疗结果至关重要.
- 在HCC中TNFα刺激基因-6 (TNFAIP6) 的作用在很大程度上是未知的.
研究的目的:
- 研究TNFAIP6在肝细胞癌中的作用和机制.
- 评估TNFAIP6作为HCC的潜在治疗点.
主要方法:
- 定量实时PCR和免疫组织化学评估TNFAIP6表达.
- 细胞增殖,入侵和迁移测定用于评估HCC细胞恶性瘤.
- 海马XF分析以测量有氧糖解.
- 西方斑,共免疫沉和染色素免疫沉以阐明分子机制.
主要成果:
- 在HCC中,TNFAIP6显著上调,与预后不佳相关.
- 降低TNFAIP6的调节抑制了HCC细胞的增殖,入侵,迁移和糖解.
- TNFAIP6与HNRNPC相互作用以稳定c-MycmRNA,通过PKM2上调促进糖解.
结论:
- TNFAIP6通过增强有氧糖解促进HCC恶性瘤.
- TNFAIP6/HNRNPC/c-Myc/PKM2轴代表了HCC的一个新型分子机制.
- 抑制TNFAIP6为HCC管理提供了潜在的治疗策略.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
MAPK Signaling Cascades
5.4K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.4K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K


